
John Barbieri
Researcher
3
APPEARANCES
2
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Aug 17, 2026
Ep 4. Acne Management with Dr. John Barbieri, MD
1:00
1:08
1:20
1:30
1:38
14:02

Jonny HatchHOST
What should you look for on your physical exam? What types of questions should you be asking so that you can have a good presentation to your attending?

John BarbieriGUEST
One of the first things to look for is just to make sure it is acne because some people come in, they're bothered by pimple-like things that might not be acne.

John BarbieriGUEST
So if you go and you evaluate that patient and they don't have comedones, that's a sign that you should be thinking more about things like periorficial dermatitis or rosacea or piteous boron folliculitis.

John BarbieriGUEST
So that's one of the first things to look for is are there comedones? If there are comedones, then you're really in the acne space.

John BarbieriGUEST
And to just briefly touch on them, periofacial dermatitis, you'll often see these inflammatory papules, sometimes pustules, they'll be clustered kind of around the periofacial areas.
12 MINS LATER

Jonny HatchHOST
How do you approach starting this patient? What dose are you starting them on? Are you starting on them on any adjunct therapies to reduce side effects?
Beyond Isotretinoin: Long Term Management, Controversies, and What’s Next in Acne
1:33
1:47
1:56
2:24

John BarbieriGUEST
So I think let's just start with the data on the really outcomes that we worry about, which are like depression, antidepressant use, and suicidality with isotretinoin.

John BarbieriGUEST
Both anecdotally, I feel like I've seen people who've developed mood lability, including sadness and depression, as well as irritability from it and have had improvement when they stopped it.

John BarbieriGUEST
and there's certainly these challenging challenge studies that i think are compelling where people take the drug they have these symptoms they stop they feel better they take it again they recur so i really do think that this can happen that's the first thing right that being said when you look at the observational data so you look at these big cohort studies that compare people who are treated with isotrinoin versus people get treated with other drugs like oral antibiotics other treatments for monitor acne those who get treated with isotrinoin consistently have lower rates of depression, antidepressant use, and suicidality.

John BarbieriGUEST
So if the decision is to be on isotretinoin or be on something else for acne, there I think the expected value is you're actually less likely to get a psychiatric comorbidity or complication on isotretinoin than other treatments.
Optimizing Isotretinoin: Clinical Pearls That Change Practice Tomorrow
4:58
5:02

John BarbieriGUEST
You know, when we think about isotranone, again, we have this, like, there's not a right dose for everyone.

John BarbieriGUEST
So what are some, one thing we want to understand are what are factors that predict long-term clearance and just kind of how often does this happen? I think, unfortunately, many people view isotranone as a cure for acne.
22 MINS LATER
